SCHEMBL7344979

SCHEMBL7344979

CC(C)C(NC(=O)OCc1cccnc1)OC(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OC(NC(=O)OCc1cccnc1)C(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.57
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
SLC22A2 O15244 1/20 0.45
SLC22A1 O15245 1/20 0.45
ABCC3 O15438 1/20 0.45
ABCC4 O15439 1/20 0.45
MLNR O43193 1/20 0.45
NR1I2 O75469 1/20 0.45
SLCO2B1 O94956 1/20 0.45
ABCB11 O95342 1/20 0.45
ALDH1A1 P00352 1/20 0.45
PGR P06401 1/20 0.45
ABCB1 P08183 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CYP2D6 P10635 1/20 0.45
CHRM1 P11229 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7357618 0.91 CYP3A4 (0.64) CYP3A4MAPTMEN1SLC22A2SLC22A1
SCHEMBL7303011 0.90 CYP3A4 (0.63) CYP3A4MAPTMEN1SLC22A2SLC22A1
SCHEMBL7569915 0.90 CYP3A4 (0.63) CYP3A4MAPTMEN1SLC22A2SLC22A1
SCHEMBL7305488 0.90 CYP3A4 (0.63) CYP3A4MAPTMEN1SLC22A2SLC22A1
SCHEMBL7298935 0.86 CYP3A4 (0.56) CYP3A4MAPTMEN1SLC22A2SLC22A1
SCHEMBL7312307 0.86 CYP3A4 (0.58) CYP3A4MAPTMEN1SLC22A2SLC22A1
SCHEMBL7311171 0.85 CYP3A4 (0.59) CYP3A4CTSLCTSB
SCHEMBL7305834 0.85 CYP3A4 (0.59) CYP3A4CTSLCTSB
SCHEMBL7565435 0.85 CYP3A4 (0.59) CYP3A4CTSLCTSB
SCHEMBL9004989 0.83 CYP3A4 (0.56) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed